Industry | 2019.08.23
Breakthrough Genomics & EpigeneticsRx Partner to Further Functional Genomic Analysis and Innovations for the Medical Industry
Goldman Sachs has projected genomics to become a $5 trillion market globally, but most genetic data is not yet easily applicable to patient care. At the same time, consumers are increasingly trying to better understand how genetics affects their health.
(PRWeb August 23, 2019)
Read the full story at https://www.prweb.com/releases/breakthrough_genomics_epigeneticsrx_partner_to_further_functional_genomic_analysis_and_innovations_for_the_medical_industry/prweb16521832.htm
For more information, please visit
https://www.prweb.com/releases/breakthro[...]cal_industry/prweb16521832.htm
